Black Diamond Ventures
4+ companies
6 partners
Meet the Team
Portfolio Companies (4)
Other
Lyric Bio
Lyric Bio, Inc. is leveraging ultra-fast bioprinting technology licensed from Prellis Biologics, Inc that can deliver bioreactors with cell densities that match human tissue for therapeutics production. The technology will drive massive gains in efficiency, and for the first time, allow several donor derived therapies to be manufactured in bioreactors. Lyric Bio is excited to deliver both cost reduction and flexible biomanufacturing to the donor-derived therapeutics market.
App Orchid
Delivering an Ontology-Driven Semantic Intelligence Layer to Generate Predictive, Explainable Insights at Scale.
Ares Materials
Novel Transparent Polymer Materials for the Next Generation Electronics.
Prellis Biologics
Creating Better Medicines Faster to Serve Patients Most in Need.
- •Address your outreach to a specific partner, such as David Lynch, Ph.D., Partner.
- •A warm introduction beats a cold email. Get matched and request an intro.
Fundraising resources
Frequently Asked Questions
See if Black Diamond Ventures is a match for your startup
Upload your pitch deck to see how well you match with Black Diamond Ventures and 10,000+ other investors.
Is this your profile? Request a correction or removal